Book a demo

Chemical intelligence powered by cypris.ai

Tachysterol3

(1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol · also: tacalciol · Tachysterol 3 · (6E)-tacalciol · Cholecalciferol Impurity E · Cholecalciferol EP Impurity E · (3b,6E)-9,10-Secocholesta-5(10),6,8-trien-3-ol

FormulaC27H44O
Mol. weight384.648
PubChem CID5283713
InChIKeyYUGCAAVRZWBXEQ-FMCTZRJNSA-N
SMILESCC1=C(C[C@H](CC1)O)/C=C/C2=CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C
113Patents
55Research papers
3Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Abbott Laboratories17
2Ono Pharmaceutical Co Ltd17
3Yarrow Bioscience Inc5
4Boston University3
5Koninklijke Philips NV3
6University of California3
7Bayer AG2
8Fortress Biotech Inc2
9Roche Holding AG2
10Zhejiang University2

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations67
2A61PTherapeutic activity (drug indications)53
3C07DHeterocyclic compounds33
4C07CAcyclic and carbocyclic compounds28
5C07BGeneral methods of organic chemistry21
6A61QCosmetics, personal care15
7C07J10
8C07KPeptides8
9A23LFoods and beverages (general)6
10C08FPolymers from C=C unsaturated bonds6

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Representative patents

The filings that best characterise the patent activity around this compound, most-referenced first.

TitleYearAssigneeCited by
Foamable vehicle and pharmaceutical compositions thereof2013Yarrow Bioscience Inc165
Foamable vehicle and pharmaceutical compositions thereof2010Yarrow Bioscience Inc157
Compositions with modulating agents2015Yarrow Bioscience Inc87
FOAMABLE VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF2007117
PURINONE DERIVATIVE HYDROCHLORIDE2013Ono Pharmaceutical Co Ltd67

How research activity has moved

Papers published per year for this compound, over the last decade of indexed records.

YearPapers
20161
20172
20182
20191
20212
20221

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Michael F. HolickMassachusetts General Hospital19
2Xiao Quan TianBoston Medical Center5
3Atsushi KittakaTeikyo University5
4Daisuke SawadaTeikyo University5
5Tai C. ChenBoston University5
6Yuya TsukudaTeikyo University4
7Kazuya TakenouchiTeijin (Japan)4
8Shinji KakudaTeijin (Japan)3
9Luis CastedoUniversidade de Santiago de Compostela3
10J. A. MacLaughlinMassachusetts General Hospital3

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of Tachysterol3?

Tachysterol3 has the molecular formula C27H44O and a molecular weight of 384.648.

Which organizations hold the most patents related to Tachysterol3?

Abbott Laboratories and Ono Pharmaceutical Co Ltd each hold 17 patents related to Tachysterol3, making them the leading patent assignees for this compound.

What are the common alternative names for Tachysterol3?

Tachysterol3 is also known by several synonyms including tacalciol, Tachysterol 3, (6E)-tacalciol, and Cholecalciferol Impurity E, reflecting its relationship to cholecalciferol compounds.

Who is the most prolific author publishing research on this compound?

Michael F. Holick from Massachusetts General Hospital is the most prolific author, having published 19 papers related to Tachysterol3.

What patent classification areas dominate the intellectual property landscape for Tachysterol3?

The dominant patent classifications are A61K (pharmaceutical preparations, 67 patents), A61P (therapeutic applications, 53 patents), and C07D (organic chemistry compounds, 33 patents), indicating a focus on pharmaceutical and medicinal chemistry applications.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial